Ben Stone
Corporate Officer/Principal bei ANAPTYSBIO, INC.
Ursprung des Netzwerks ersten Grades von Ben Stone
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ben Stone
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Biotechnology Value Fund LP
 Biotechnology Value Fund LP Investment ManagersFinance Part of BVF, Inc., Biotechnology Value Fund LP is an Alternative Investment Manager. The company is based in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director of Finance/CFO | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ATRECA, INC. | Biotechnology | Chief Executive Officer | |
| AFFYMAX, INC. | Biotechnology | Chairman Chief Executive Officer | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| Kalamazoo College | College/University | Undergraduate Degree | |
| New York University | College/University | Masters Business Admin | |
| University of Western Ontario | College/University | Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| University of San Diego | College/University | Undergraduate Degree Masters Business Admin | |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RELYPSA INC | Pharmaceuticals: Major | Chief Executive Officer | |
| Mercersburg Academy | College/University | Undergraduate Degree | |
| Diabetogen Biosciences, Inc. | Corporate Officer/Principal | ||
| PFENEX INC. | Biotechnology | Director/Board Member Director/Board Member | |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Richard Ivey School of Business | College/University | Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Public Communications Contact Corporate Officer/Principal | |
| AVROBIO, INC. | Biotechnology | Public Communications Contact | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Chief Executive Officer | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Trotana, Inc.
 Trotana, Inc. BiotechnologyHealth Technology Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria. | Biotechnology | Chief Executive Officer | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chairman |
Statistik
International
| Vereinigte Staaten | 46 |
| Kanada | 4 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 11 |
| Finance | 4 |
| Health Services | 4 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 145 |
| Independent Dir/Board Member | 59 |
| Corporate Officer/Principal | 51 |
| Undergraduate Degree | 22 |
| Director of Finance/CFO | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Topper | 49 |
| Magda Marquet | 30 |
| Dennis Fenton | 28 |
| John Schmid | 24 |
| John Orwin | 21 |
| Hollings Renton | 17 |
| Oleg Nodelman | 15 |
| Laura Hamill | 15 |
| Rita Jain | 14 |
| Eric Loumeau | 11 |
| Dennis Mulroy | 10 |
| Paul Lizzul | 10 |
| J. Ware | 9 |
| Hamza Suria | 9 |
| Daniel Faga | 7 |